Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026)

Green Thumb Industries (GTBIF) posted Cash from Financing Activities of $5.7 million for Q1 2026, up 127.02% on a QoQ basis from -$21.1 million in Q4 2025, and up 219.97% year-over-year from $1.8 million in Q1 2025.

Green Thumb Industries (GTBIF) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Green Thumb Industries' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 219.97% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.5 million (up 54.46% YoY) and the FY2025 annual result came in at -$50.9 million, up 46.71% from the prior year.
  • Cash from Financing Activities was $5.7 million for Q1 2026 at Green Thumb Industries, up from -$21.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $18.9 million in Q4 2022 and bottomed at -$51.1 million in Q3 2024.
  • A 5-year average of -$8.5 million and a median of -$5.8 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 10420.0% — and 2024, when it sank 8320.59%.
  • Green Thumb Industries' Cash from Financing Activities stood at $18.9 million in 2022, then slumped by 130.97% to -$5.8 million in 2023, then sank by 57.38% to -$9.2 million in 2024, then slumped by 129.8% to -$21.1 million in 2025, then jumped by 127.02% to $5.7 million in 2026.
  • Business Quant data shows GTBIF's Cash from Financing Activities at $5.7 million in Q1 2026, -$21.1 million in Q4 2025, and -$2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn 5.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.71 Mn
Mar 31, 2026 5.71 Mn
Dec 31, 2025 -21.12 Mn
Dec 31, 2025 -21.12 Mn
Sep 30, 2025 -2.63 Mn
Sep 30, 2025 -2.63 Mn
Jun 30, 2025 -22.43 Mn
Jun 30, 2025 -22.43 Mn
Mar 31, 2025 -4.76 Mn
Mar 31, 2025 -4.76 Mn
Dec 31, 2024 -9.19 Mn
Dec 31, 2024 -9.19 Mn
Sep 30, 2024 -51.06 Mn
Sep 30, 2024 -51.06 Mn
Jun 30, 2024 -23.89 Mn
Jun 30, 2024 -23.89 Mn
Mar 31, 2024 -11.45 Mn
Mar 31, 2024 -11.45 Mn
Dec 31, 2023 -5.84 Mn
Dec 31, 2023 -5.84 Mn